UROsphere to present scientific results at AUA annual meeting (USA, 25-30 April 2009)
Following posters will be presented in different sessions:
- Deba A, Lluel P, Palea S. Functional evidence of β3-adrenoceptors (β3-AR) in female mouse isolated urinary bladder.
- Deba A, Palea S, Parini A, Lluel P. Differential gene expression in bladder hypertrophy following bladder outlet obstruction in mouse.
- Lluel P, Guilloteau V, Guerard M, Pietra C, Lovati E, Palea S. Netupitant, a new selective NK1 receptor antagonist, reverses acetic acid-induced bladder overactivity in anesthetized female guinea-pigs.
- Palea S, Gilles N, Guerard M, Lluel P. AdTx1, a new peptidic α1A-adrenoceptor antagonist: in vivo pharmacological characterization.
UROsphere's top management will be present during the meeting. If you wish to meet them, please
UROsphere to present scientific results at EAU annual meeting (Stockholm, Sweden, 17-21 March , 2009)
UROsphere will take part in the European Association of Urology's Annual Meeting and present scientific results on BPH research:
Gilles N, Lluel P, Rekik M, Guerard M, Palea S. AdTx1, a new peptidic α1-adrenoceptor antagonist with high affinity and selectivity for human α1A-adrenoceptor subtype: pharmacological characterization.
The company's top managers will also present the company's expertise to members of the Medicon Valley biotech cluster (in Sweden and Denmark) in March 2009.
To read the press release, click here .